放射组学方法预测宫颈癌或子宫内膜癌接受外照射放疗患者急性血液学毒性
本研究回顾性纳入三个队列共207例宫颈癌或子宫内膜癌患者,从计划CT提取盆腔骨髓放射组学特征并结合临床变量构建联合模型,预测放疗期间急性严重血液学毒性。联合模型在训练集、内部测试集和外部测试集的AUC分别为0.88(95%CI 0.81-0.93)、0.80(95%CI 0.62-0.92)和0.85(95%CI 0.71-0.94),优于单独临床或放射组学模型。
要点
- 联合模型含FIGO分期、术后化疗周期数和放射组学评分,训练集AUC 0.88(95%CI 0.81-0.93)。
- 内部测试集AUC 0.80(95%CI 0.62-0.92),外部测试集AUC 0.85(95%CI 0.71-0.94)。
- 联合模型AUC优于单独临床或放射组学特征模型。
核心结论
- 包含放射组学特征和临床因素的联合模型在AUC方面优于单独基于临床或放射组学特征的模型。
- 盆腔骨髓放射组学在放化疗所致血液学毒性中的价值值得进一步研究。
研究设计与样本
- 回顾性纳入三个队列共207例宫颈癌或子宫内膜癌患者。
- 纳入41个临床变量和从计划CT扫描提取的2226个盆腔骨髓放射组学特征进行模型构建。
- 经特征选择后分别通过机器学习训练临床模型和放射组学模型,并将放射组学评分与临床模型筛选的变量整合构建联合模型。
- 采用受试者工作特征曲线下面积(AUC)评估模型性能。
主要发现
- 最佳预测模型包含两个临床特征(FIGO分期和术后化疗周期数)和放射组学评分。
- 联合模型在训练集AUC为0.88(95%CI 0.81-0.93),内部测试集AUC为0.80(95%CI 0.62-0.92),外部测试集AUC为0.85(95%CI 0.71-0.94)。
关键数值与推荐
- 联合模型训练集AUC 0.88(95%CI 0.81-0.93)。
- 联合模型内部测试集AUC 0.80(95%CI 0.62-0.92)。
- 联合模型外部测试集AUC 0.85(95%CI 0.71-0.94)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出盆腔骨髓放射组学在放化疗所致血液学毒性中的价值值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study is purposed to establish a predictive model for acute severe hematologic toxicity (HT) during radiotherapy in patients with cervical or endometrial cancer and investigate whether the integration of clinical features and computed tomography (CT) radiomics features of the pelvic bone marrow (BM) could define a more precise model. METHODS: A total of 207 patients with cervical or endometrial cancer from three cohorts were retrospectively included in this study. Forty-one clinical variables and 2226 pelvic BM radiomic features that were extracted from planning CT scans were included in the model construction. Following feature selection, model training was performed on the clinical and radiomics features via machine learning, respectively. The radiomics score, which was the output of the final radiomics model, was integrated with the variables that were selected by the clinical model to construct a combined model. The performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC). RESULTS: The best-performing prediction model comprised two clinical features (FIGO stage and cycles of postoperative chemotherapy) and radiomics score and achieved an AUC of 0.88 (95% CI, 0.81-0.93) in the training set, 0.80 (95% CI, 0.62-0.92) in the internal-test set and 0.85 (95% CI, 0.71-0.94) in the external-test dataset. CONCLUSION: The proposed model which incorporates radiomics signature and clinical factors outperforms the models based on clinical or radiomics features alone in terms of the AUC. The value of the pelvic BM radiomics in chemoradiotherapy-induced HT is worthy of further investigation.
引用
- Le Z, Wu D, Chen X, et al. A radiomics approach for predicting acute hematologic toxicity in patients with cervical or endometrial cancer undergoing external-beam radiotherapy. Radiother Oncol. 2023. PMID: 36706957. doi:10.1016/j.radonc.2023.109489
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。